Andrew Albert Kucharchuk serves as Executive at OncBioMune Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Andrew Albert Kucharchuk has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 7, 2026 involved receiving (via award) 1,162,099 shares valued at $0.
Andrew Albert Kucharchuk currently holds 1,162,099 shares of OncBioMune Pharmaceuticals, Inc (OBMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Albert Kucharchuk has been a net neutral trader of OBMP stock. They have purchased $0 and sold $0 worth of shares.
Andrew Albert Kucharchuk's most recent insider trade was on Jan 7, 2026, when they sold 1,162,099 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.06 |
| Discretionary |
| Sep 2, 2015 | OBMP | $0 | Award | 5,000,000 | $N/A | Discretionary |